Retrospective Analysis of Quality of Life After Permanent Interstitial Iodine Seed Brachytherapy for Prostate Cancer


Condition: Neoplasms, Prostate

Study Type: Observational

Clinical Trials Identifier NCT 8-digits: NCT02652000

Sponsor: Kantonsspital Graubuenden

Phase:

Eligibility:

  • Age: minimum 48 Years maximum 80 Years
  • Gender: Male

Inclusion Criteria:

  • Male > 18 years of age
  • iodine seed brachytherapy for localized prostate cancer at the University Hospital Zurich

Exclusion Criteria:

  • No iodine seed brachytherapy for localized prostate cancer at the University Hospital Zurich

View trial on ClinicalTrials.gov